GovWire

Meflosyl 5% Solution for Injection SPC change

Veterinary Medicines Directorate

January 13
11:09 2025

class="gem-c-govspeak govuk-govspeak gem-c-govspeak--direction-ltr govuk-!-margin-bottom-0">

Any veterinary medicinal product which is authorised for marketing in the UK will have its Summary of Product Characteristics (SPC) available on our Product Information Database which can be accessed at https://www.vmd.defra.gov.uk/productinformationdatabase/.

No medicine is 100% risk free, the SPC includes information on what adverse events have been known to occur following administration of a particular product, these can be found in either section Adverse events (3.6) or Adverse reactions (4.6).

Following monitoring of pharmacovigilance data, the Summary of Product Characteristics (SPC) for Meflosyl 5% Solution for Injection has been updated:

Section 4.6 now states that in very rare cases allergic reactions (anaphylaxis) may occur after administration of the veterinary medicinal product.

All updates to SPCs other than template changes, are published in the medicine updates section of VMD Connect which can be accessed at: https://www.vmdconne

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: